Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management

Inclusion Criteria: * Patient is 18 years of age or older and has given formal written consent. * Diagnosed with a chronic, exuding lower extremity wound of a single limb: * Venous leg ulcer (VLU) or * Diabetic Foot Ulcer (DFU). * Target ulcer persists since min. 1 and max. 12 months prior to screening. * An appropriate dressing size is available to be used according to the size of the target ulcer, the ulcer size shall be no longer than 10 cm in one dimension. * Target ulcer is not clinically infected ( Clinically infected wound is defined as a wound that required the use of systemic antibiotics or topical antimicrobials ). * Ankle-brachial pressure index (ABPI) is between 0.8 and 1.2 measured during the Screening or within 30 days prior to the Screening Visit. If ABPI is \>1.2 the Toe-Brachial Index (TBI) should be \>0.6. * Presence of an ulcer extending through the full thickness of the skin but not down to muscle, tendon or bone. * For VLU: Patient is suitable for and agrees to use compression therapy (PütterPro2 or PütterPro2 Lite) for the study duration and was using compression therapy before study inclusion. * For VLU: Patient is able to walk in conjunction to compression therapy. Ankle mobility is fully mobile to limited mobile. * For DFU: Patient is suitable and agrees to use offloading devises for the study duration. * For DFU: Patient is able to walk in conjunction to offloading devices. Ankle mobility is fully mobile to limited mobile. Exclusion Criteria: …